{"id":3200,"date":"2021-04-22T09:45:42","date_gmt":"2021-04-22T08:45:42","guid":{"rendered":"https:\/\/world-heart-federation.org\/?page_id=3200"},"modified":"2021-04-23T15:47:06","modified_gmt":"2021-04-23T14:47:06","slug":"glo-pro","status":"publish","type":"page","link":"https:\/\/world-heart-federation.org\/emerging-leaders\/projects\/glo-pro\/","title":{"rendered":"GLO-PRO"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"
A GLObal PROcess level view of access to priority WHO essential medicines for cardiovascular diseases: Towards a citizen science intervention<\/p>\n","protected":false},"author":1,"featured_media":4023,"parent":2203,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/flexible-template.php","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"topic":[],"class_list":["post-3200","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n